Involvement of the mitogen-activated protein kinase cascade in peroxynitrite-mediated arachidonic acid release in vascular smooth muscle cells

American Journal of Physiology - Cell Physiology

Volumn 286, Issue 6 55-6, 2004, Pages

  Upmacis, Rita K ^a   Deeb, Ruba S ^a   Resnick, Matthew J ^a   Lindenbaum, Rochelle ^a   Gamss, Caryn ^a   Mittar, Dev ^a   Hajjar, David P ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Cytosolic phospholipase A2; Extracellular signal regulated kinase; p38; Prostaglandin H2 synthase; Reactive nitrogen species

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ARACHIDONIC ACID; ICOSANOID; INDUCIBLE NITRIC OXIDE SYNTHASE; LINSIDOMINE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; N [2 [[N [3 (4 CHLOROPHENYL) 2 PROPENYL] N METHYLAMINO]METHYL]PHENYL] N (2 HYDROXYETHYL) 4 METHOXYBENZENESULFONAMIDE; PEROXYNITRITE; PHOSPHOLIPASE A2; REACTIVE NITROGEN SPECIES; SYNAPTOPHYSIN;

ANIMAL CELL; ARACHIDONIC ACID METABOLISM; ARTERY MUSCLE; ARTICLE; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE DELETION; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; RAT; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING;

ANIMALS; ARACHIDONIC ACID; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELLS, CULTURED; CHELATING AGENTS; DINOPROSTONE; ENZYME INHIBITORS; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASES; MOLSIDOMINE; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PEROXYNITROUS ACID; PHOSPHOLIPASES A; RATS;

ANIMALIA;

EID: 2442497183     PISSN: 03636143     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpcell.00143.2003     Document Type: Article

References (75)

1. Augusto O, Bonini MG, Amanso AM, Linares E, Santos CC, and De Menezes SL. Nitrogen dioxide and carbonate radical anion: two emerging radicals in biology. Free Radic Biol Med 32: 841-859, 2002.
2. Avruch J, Zhang XF, and Kyriakis JM. Raf meets Ras: completing the framework of a signal transduction pathway. Trends Biochem Sci 19: 279-283, 1994.
3. Bapat S, Verkleij A, and Post JA. Peroxynitrite activates mitogen-activated protein kinase (MAPK) via a MEK-independent pathway: a role for protein kinase C. FEBS Lett 499: 21-26, 2001.
4. Beckman JS, Chen J, Ischiropoulos H, and Crow JP. Oxidative chemistry of peroxynitrite. Methods Enzymol 233: 229-240, 1994.
5. Beckmann JS, Ye YZ, Anderson PG, Chen J, Accavitti MA, Tarpey MM, and White CR. Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry. Biol Chem Hoppe Seyler 375: 81-88, 1994.
6. Belton O, Byrne D, Kearney D, Leahy A, and Fitzgerald DJ. Cyclooxygenase-1 and -2-dependent prostacyclin formation in patients with atherosclerosis. Circulation 102: 840-845, 2000.
7. Boulos C, Jiang H, and Balazy M. Diffusion of peroxynitrite into the human platelet inhibits cyclooxygenase via nitration of tyrosine residues. J Pharmacol Exp Ther 293: 222-229, 2000.
8. Buttery LD, Springall DR, Chester AH, Evans TJ, Standfield EN, Parums DV, Yacoub MH, and Polak JM. Inducible nitric oxide synthase is present within human atherosclerotic lesions and promotes the formation and activity of peroxynitrite. Lab Invest 75: 77-85, 1996.
9. 2+-dependent translocation domain with homology to PKC and GAP. Cell 65: 1043-1051, 1991.
10. Cohen P. The search for physiological substrates of MAP and SAP kinases in mammalian cells. Trends Cell Biol 7: 353-361, 1997.
11. Davidge ST. Prostaglandin H synthase and vascular function. Circ Res 89: 650-660, 2001.
12. 2 expressed in insect cells and present in human monocytes. J Biol Chem 271: 6987-6997, 1996.
13. 2 synthase. J Lipid Res 43: 1718-1726, 2002.
14. De Silva DR, Jones EA, Favata MF, Jaffee BD, Magolda RL, Trzaskos JM, and Scherle PA. Inhibition of mitogen-activated protein kinase kinase blocks T cell proliferation but does not induce or prevent anergy. J Immunol 160: 4175-4181, 1998.
15. Dietz R, Nastainczyk W, and Ruf HH. Higher oxidation states of prostaglandin H synthase. Rapid electronic spectroscopy detected two spectral intermediates during the peroxidase reaction with prostaglandin G2. Eur J Biochem 171: 321-328, 1988.
16. Estevez AG, Radi R, Barbeito L, Shin JT, Thompson JA, and Beckman JS. Peroxynitrite-induced cytotoxicity in PC12 cells: evidence for an apoptotic mechanism differentially modulated by neurotrophic factors. J Neurochem 65: 1543-1550, 1995.
17. 2+/calmodulin-dependent kinase II phosphorylates the epidermal growth factor receptor on multiple sites in the cytoplasmic tail and serine 744 within the kinase domain to regulate signal generation. J Biol Chem 274: 16168-16173, 1999.
18. 2-induced interleukin-6 release in astrocytes: possible involvement of EP4-like receptors, p38 mitogen-activated protein kinase and protein kinase C. J Neurochem 79: 950-958, 2001.
19. Fitz Gerald GA, Smith B, Pedersen AK, and Brash AR. Increased prostacyclin biosynthesis in patients with severe atherosclerosis and platelet activation. N Engl J Med 310: 1065-1068, 1984.
20. Garrington TP and Johnson GL. Organization and regulation of mitogen-activated protein kinase signaling pathways. Curr Opin Cell Biol 11: 211-218, 1999.
21. 2-terminal kinase. Am J Physiol Heart Circ Physiol 277: H1647-H1653, 1999.
22. 2. Biochem J 366: 307-314, 2002.
23. Guidarelli A, Palomba L, and Cantoni O. Peroxynitrite-mediated release of arachidonic acid from PC12 cells. Br J Pharmacol 129: 1539-1541, 2000.
24. 2 by MNK1-related protein kinases. J Biol Chem 275: 37542-37551, 2000.
25. 2. J Biol Chem 274: 5163-5169, 1999.
26. Hu Y, Dietrich H, Metzler B, Wick G, and Xu Q. Hyperexpression and activation of extracellular signal-regulated kinases (ERK1/2) in atherosclerotic lesions of cholesterol-fed rabbits. Arterioscler Thromb Vasc Biol 20: 18-26, 2000.
27. Huie RE and Padmaja S. The reaction of NO with superoxide. Free Radic Res Commun 18: 195-199, 1993.
28. Ischiropoulos H and al-Mehdi AB. Peroxynitrite-mediated oxidative protein modifications. FEBS Lett 364: 279-282, 1995.
29. Jope RS, Zhang L, and Song L. Peroxynitrite modulates the activation of p38 and extracellular regulated kinases in PC12 cells. Arch Biochem Biophys 376: 365-370, 2000.
30. 2 in vascular smooth muscle cells. J Pharmacol Exp Ther 304: 761-772, 2003.
31. Kaur H and Halliwell B. Evidence for nitric oxide-mediated oxidative damage in chronic inflammation. Nitrotyrosine in serum and synovial fluid from rheumatoid patients. FEBS Lett 350: 9-12, 1994.
32. 2). FEBS Lett 410: 49-53, 1997.
33. Kyriakis JM and Avruch J. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev 81: 807-869, 2001.
34. Landino LM, Crews BC, Timmons MD, Morrow JD, and Marnett LJ. Peroxynitrite, the coupling product of nitric oxide and superoxide, activates prostaglandin biosynthesis. Proc Natl Acad Sci USA 93: 15069-15074, 1996.
35. Lassmann G, Odenwaller R, Curtis JF, De Gray JA, Mason RP, Marnett LJ, and Eling TE. Electron spin resonance investigation of tyrosyl radicals of prostaglandin H synthase. Relation to enzyme catalysis. J Biol Chem 266: 20045-20055, 1991.
36. Lee JC, Laydon JT, McDonnell PC, Gallagher TF, Kumar S, Green D, McNulty D, Blumenthal MJ, Heys JR, Landvatter SW, Strikler JE, McLaughlin MM, Siemens IR, Fisher SM, Livi GP, White JR, Adams JL, and Young PR. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372: 739-746, 1994.
37. 2. J Biol Chem 272: 16709-16712, 1997.
38. 2 is coupled to hormonally regulated release of arachidonic acid. Proc Natl Acad Sci USA 89: 6147-6151, 1992.
39. 2 is phosphorylated and activated by MAP kinase. Cell 72: 269-278, 1993.
40. 2+/calmodulin-dependent protein kinase II inhibitor KN-93. Biochem Biophys Res Commun 195: 608-615, 1993.
41. Markwell MA, Haas SM, Bieber LL, and Tolbert NE. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem 87: 206-210, 1978.
42. Marnett LJ, Wright TL, Crews BC, Tannenbaum SR, and Morrow JD. Regulation of prostaglandin biosynthesis by nitric oxide is revealed by targeted deletion of inducible nitric-oxide synthase. J Biol Chem 275: 13427-13430, 2000.
43. 2 in norepinephrine-induced arachidonic acid release in rabbit aortic smooth muscle cells. J Biol Chem 271: 30149-30157, 1996.
44. 2. J Biol Chem 276: 39653-39660, 2001.
45. 2 by p42 microtubule-associated protein 2 kinase and protein kinase C. J Biol Chem 268: 1960-1964, 1993.
46. Nogawa S, Forster C, Zhang F, Nagayama M, Ross ME, and Iadecola C. Interaction between inducible nitric oxide synthase and cyclooxygenase-2 after cerebral ischemia. Proc Natl Acad Sci USA 95: 10966-10971, 1998.
47. 2 synthesis by plasma high and low density lipoproteins. Circ Res 54: 554-565, 1984.
48. Radi R, Beckman JS, Bush KM, and Freeman BA. Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide. J Biol Chem 266: 4244-4250, 1991.
49. Radi R, Beckman JS, Bush KM, and Freeman BA. Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide. Arch Biochem Biophys 288: 481-487, 1991.
50. Radi R, Denicola A, and Freeman BA. Peroxynitrite reactions with carbon dioxide-bicarbonate. Methods Enzymol 301: 353-367, 1999.
51. Reddy MA, Thimmalapura PR, Lanting L, Nadler JL, Fatima S, and Natarajan R. The oxidized lipid and lipoxygenase product 12(S)-hydroxyeicosatetraenoic acid induces hypertrophy and fibronectin transcription in vascular smooth muscle cells via p38 MAPK and cAMP response element-binding protein activation. Mediation of angiotensin II effects. J Biol Chem 277: 9920-9928, 2002.
52. Rimarachin JA, Jacobson JA, Szabo P, Maclouf J, Creminon C, and Weksler BB. Regulation of cyclooxygenase-2 expression in aortic smooth muscle cells. Arterioscler Thromb 14: 1021-1031, 1994.
53. Rosenkranz B, Winkelmann BR, and Parnham MJ. Clinical pharmacokinetics of molsidomine. Clin Pharmacokinet 30: 372-384, 1996.
54. Salvemini D, Misko TP, Masferrer JL, Seibert K, Currie MG, and Needleman P. Nitric oxide activates cyclooxygenase enzymes. Proc Natl Acad Sci USA 90: 7240-7244, 1993.
55. Salvemini D, Seibert K, Masferrer JL, Misko TP, Currie MG, and Needleman P. Endogenous nitric oxide enhances prostaglandin production in a model of renal inflammation. J Clin Invest 93: 1940-1947, 1994.
56. Salvemini D, Settle SL, Masferrer JL, Seibert K, Currie MG, and Needleman P. Regulation of prostaglandin production by nitric oxide; an in vivo analysis. Br J Pharmacol 114: 1171-1178, 1995.
57. Sautebin L, Ialenti A, Ianaro A, and Di Rosa M. Modulation by nitric oxide of prostaglandin biosynthesis in the rat. Br J Pharmacol 114: 323-328, 1995.
58. Schieke SM, Briviba K, Klotz LO, and Sies H. Activation pattern of mitogen-activated protein kinases elicited by peroxynitrite: attenuation by selenite supplementation. FEBS Lett 448: 301-303, 1999.
59. Schmidt P, Youhnovski N, Daiber A, Balan A, Arsic M, Bachschmid M, Przybylski M, and Ullrich V. Specific nitration at tyrosine 430 revealed by high resolution mass spectrometry as basis for redox regulation of bovine prostacyclin synthase. J Biol Chem 278: 12813-12819, 2003.
60. Schonbeck U, Sukhova GK, Graber P, Coulter S, and Libby P. Augmented expression of cyclooxygenase-2 in human atherosclerotic lesions. Am J Pathol 155: 1281-1291, 1999.
61. Soderling TR. Protein kinases. Regulation by autoinhibitory domains. J Biol Chem 265: 1823-1826, 1990.
62. Stamler JS, Singel DJ, and Loscalzo J. Biochemistry of nitric oxide and its redox-activated forms. Science 258: 1898-1902, 1992.
63. Upmacis RK, Deeb RS, and Hajjar DP. Regulation of prostaglandin H2 synthase activity by nitrogen oxides. Biochemistry 38: 12505-12513, 1999.
64. Upmacis RK, Deeb RS, and Hajjar DP. Role of nitrogen oxides on eicosanoid production during atherosclerosis: understanding the controversies. Curr Atheroscler Rep 3: 181-182, 2001.
65. Van der Vliet A, Hristova M, Cross CE, Eiserich JP, and Goldkorn T. Peroxynitrite induces covalent dimerization of epidermal growth factor receptors in A431 epidermoid carcinoma cells. J Biol Chem 273: 31860-31866, 1998.
66. 2 are abrogated by an inhibitor of the p38 mitogen-activated protein kinase cascade in human neutrophils. Biochem J 319: 17-20, 1996.
67. Wen Y, Gu J, Knaus UG, Thomas L, Gonzales N, and Nadler JL. Evidence that 12-lipoxygenase product 12-hydroxyeicosatetraenoic acid activates p21-activated kinase. Biochem. J 349: 481-487, 2000.
68. Widmann C, Gibson S, Jarpe MB, and Johnson GL. Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. Physiol Rev 79: 143-180, 1999.
69. Xia Y and Zweier JL. Superoxide and peroxynitrite generation from inducible nitric oxide synthase in macrophages. Proc Natl Acad Sci USA 94: 6954-6958, 1997.
70. 2 from cytosol to membranes in rat brain induced by calcium ions. Biochem Biophys Res Commun 170: 484-490, 1990.
71. Zhang P, Wang YZ, Kagan E, and Bonner JC. Peroxynitrite targets the epidermal growth factor receptor, Raf-1, and MEK independently to activate MAPK. J Biol Chem 275: 22479-22486, 2000.
72. Zhu L, Gunn C, and Beckman JS. Bactericidal activity of peroxynitrite. Arch Biochem Biophys 298: 452-457, 1992.
73. Zou M, Martin C, and Ullrich V. Tyrosine nitration as a mechanism of selective inactivation of prostacyclin synthase by peroxynitrite. Biol Chem 378: 707-713, 1997.
74. Zou MH, Leist M, and Ullrich V. Selective nitration of prostacyclin synthase and defective vasorelaxation in atherosclerotic bovine coronary arteries. Am J Pathol 154: 1359-1365, 1999.
75. Zou MH and Ullrich V. Peroxynitrite formed by simultaneous generation of nitric oxide and superoxide selectively inhibits bovine aortic prostacyclin synthase. FEBS Lett 382: 101-104, 1996.